Viracept and Juluca drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Viracept (nelfinavir mesylate) and Juluca (dolutegravir sodium; rilpivirine hydrochloride). Common drug interactions include chronic kidney disease among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Viracept and Juluca. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,399 Viracept users. Check the latest studies of Viracept.

What is Juluca?

Juluca has active ingredients of dolutegravir sodium; rilpivirine hydrochloride. eHealthMe is studying from 1,732 Juluca users. Check the latest studies of Juluca.

On Jul, 27, 2026

39 people who take Viracept and Juluca together, and have interactions are studied.

What are the common drug interactions of Viracept and Juluca, by gender? *:

female:

Chronic kidney disease
Emotional distress
Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Fatigue (feeling of tiredness)
Renal failure (kidney dysfunction)
Quality of life decreased
Depression
Tooth loss

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Renal transplant
Tooth loss
Bone density decreased
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Decreased activity
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Impaired work ability

What are the common drug interactions of Viracept and Juluca, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Decreased activity
Depression
Dyspnoea (difficult or laboured respiration)
Emotional distress
Fatigue (feeling of tiredness)
Hallucination (an experience involving the perception of something not present)
Impaired work ability
Osteoporosis (bones weak and more likely to break)

30-39:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Depression
Emotional distress
Fatigue (feeling of tiredness)
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Pain
Quality of life decreased
Renal failure (kidney dysfunction)
Asthenia (weakness)

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Decreased activity
Hyperkalaemia (damage to or disease of the kidney)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

50-59:

Emotional distress
Pain
Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Renal failure (kidney dysfunction)
Fibula fracture
Osteoporosis (bones weak and more likely to break)
Ankle fracture

60+:

Abdominal pain upper
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Back pain
Chronic kidney disease
Disturbance in attention
Emotional distress
Fatigue (feeling of tiredness)
Pain

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 17.95%
High Blood Cholesterol: 6 people, 15.38%
Diabetes: 5 people, 12.82%
Procedural Pain: 4 people, 10.26%
Infection: 4 people, 10.26%
Pain: 3 people, 7.69%
Stress And Anxiety: 2 people, 5.13%
Depression: 2 people, 5.13%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Viracept and Juluca?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously